
About Madorra
Madorra is a Healthcare company based in Portland (United States) founded in 2014 by Holly Rockweiler and Ryan Krone. Therapeutic device for vaginal atrophy and dryness treatment is provided. It operates on a HealthTech model. Madorra has raised $4 million across 6 funding rounds from investors including HHS, OneVentures and OTRADI. The company has 6 employees. Its chief executive, as recorded, is Holly Rockweiler. Madorra offers products and services including Nonhormonal Vaginal Health Device. Its focus areas include Medical Devices and Women's Health Devices. Its legal entity is MADORRA INC. Its competitors include Bioceptive and Impact Medical Innovations; 2 of its 2 listed competitors have raised funding.
Company details
Solutions for post-menopausal women and breast cancer survivors are developed by Madorra. A nonhormonal and noninvasive approach to treating vaginal dryness is provided, addressing moderate to severe vulvovaginal atrophy. The healthcare sector, specifically womens health, is targeted with innovative medical devices. Empowerment through choice in vaginal health management is emphasized. Breakthrough device designation status has been received for their primary solution.
- Headquarters Portland, United States
- Employees 6
- Founders Holly Rockweiler, Ryan Krone
- SectorsHealthcare
- Email••••••••
- Website madorra.com
- Social LinkedIn X Facebook
- Legal Name Madorra Inc.
- Total Equity Funding$4M (USD)
in 6 rounds
- Latest Funding Round$1.51M (USD), Grant
Sep 2024
- InvestorsHHS
& 3 more
- Employee Count6
Products & Services of Madorra
Madorra offers a comprehensive portfolio of products and services, including Nonhormonal Vaginal Health Device.
A noninvasive solution for vaginal dryness is provided.
Funding Insights of Madorra
Madorra has successfully raised a total of $4M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.51 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4M
- Total Rounds 6
- Last Round Grant — $1.51M
- First Round $174,831
(Jan 2016)
- Investors Count 4
All 6 funding rounds of Madorra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $1.51M | Grant | – | – | |
| Sep 2018 | $4M | Series A | – | – | |
| Aug 2018 | $2.3M | Grant | – | – | |
| Apr 2017 | $275,000 | Grant | – | – | |
| Mar 2017 | $1.42M | Grant | – | – | |
| Jan 2016 | $174,831 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Madorra
Madorra has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, OneVentures and OTRADI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering growth equity and credit for technology and healthcare companies. | one-ventures.com.au | |||
Bioscience startups are incubated by OTRADI in Portland, Oregon. | otradi.org | Portland, United States | ||
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Madorra
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Madorra
5 people are tracked at Madorra (4 in leadership, 1 in team); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Holly Rockweiler | Co-Founder & CEO | Leadership |
Ryan Krone | Co-Founder | Leadership |
Robert Blante | Senior Director of Operations and Manufacturing Engineering | Leadership |
Bryan Flaherty | Chief Technology Officer | Leadership |
Sara Lashanlo | Mechanical Engineer | Team |
Complete people profiles for Madorra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Madorra
3 dated milestones of Madorra across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Madorra is founded.
- Funding First funding round of $175K.
- Funding Latest funding round, Grant, of $1.5M.
Competitors of Madorra
Madorra has 2 listed competitors in our database, 2 of them funded. They include Bioceptive and Impact Medical Innovations.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioceptive.com | 2010 | New Orleans, United States | $2.94M | 2 | Medical devices for gynecological procedures are developed. | |
| impactmedicalinnovations.com | 2008 | Boca Raton, United States | $250,000 | Developer of medical device and diagnostics in point-of-care diagnostics and women’s health |
Detailed competitors of Madorra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Madorra (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Madorra
Complete news archive for Madorra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madorra
Madorra was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Madorra is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Holly Rockweiler is the CEO of Madorra, as recorded in our data. They have also founded this company.
Madorra is a funded company, having raised a total of $4M across 6 funding rounds to date. The company's 1st funding round was a Grant of $174.83K, raised on Jan 2016.
Madorra has 6 employees.
Solutions for post-menopausal women and breast cancer survivors are developed by Madorra. A nonhormonal and noninvasive approach to treating vaginal dryness is provided, addressing moderate to severe vulvovaginal atrophy. The healthcare sector, specifically womens health, is targeted with innovative medical devices. Empowerment through choice in vaginal health management is emphasized. Breakthrough device designation status has been received for their primary solution.
Madorra's top competitors include Bioceptive and Impact Medical Innovations.
Madorra offers Nonhormonal Vaginal Health Device.
Madorra has 4 investors. Key investors include HHS, OneVentures, OTRADI, and America’s Seed Fund.
Madorra operates through Madorra Inc..
